QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Garth Richmond who wrote (211)	1/9/1998 7:07:00 PM
From: Michael Anthony	Read Replies (3) of 1321

The REALLY big news will be when Vertoprofin is approved for Age Related Macular Degeneration. I'm an optometrist. Trust me. The market there is bigger than all the other cancer stuff combined. When that's approved, you'll see major income. ARMD affects a huge amount of the elderly population. If the treatment is approved and covered by insurance, not only will it preserve sight that presently cannot be preserved, but we'll all make a ton on this stock. BTW, was it halted as of the close? I didn't see anything about a halt on quote.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next